Molecular mechanisms underlying the anticancer property of Dendrobium in various systems of the human body: A review.
Molecular mechanisms underlying the anticancer property of Dendrobium in various systems of the human body: A review.
复制标题
DOI:
10.1016/j.biopha.2023.115223
复制
发表时间:
2023-07
期刊:
影响因子:
--
通讯作者:
Wen-Jian Yang;Dengwang Chen;Qinglu Ji;Jishan Zheng;Yunyan Ma;H. Sun;Qian Zhang;Jidong Zhang-Jidong-Zha
中科院分区:
文献类型:
--
作者:
Wen-Jian Yang;Dengwang Chen;Qinglu Ji;Jishan Zheng;Yunyan Ma;H. Sun;Qian Zhang;Jidong Zhang-Jidong-Zha
Dendrobium,which belongs to the family of Orchidaceae, is a highly valuable traditional Chinese medicine commonly used in China. It exerts pharmacological activities such as antitumor and hypoglycemia effects, and its main components are alkaloids, polysaccharides, and terpenoids, among others. In recent years, research on the clinical application ofDendrobiumin antitumor therapy has gained increasing attention. Accumulating evidence suggests that the active components ofDendrobiumpossess significant inhibitory effects on the viability of cancer cells as evident from invivoand invitroexperiments, which indicates thatDendrobiumexerts significant anticancer effect in treating and preventing cancer development, inhibiting the underlying potential molecular mechanisms, including suppression of cancer cell growth and proliferation, epithelial-mesenchymal transition (EMT), apoptosis induction, tumor angiogenesis, and reinforcement of cisplatin (DDP) -induced apoptosis. We herein present a review that summarizes the research progress of the application ofDendrobiumin cancer therapy and its molecular mechanisms. This review describes the positive aspects of the active ingredients ofDendrobiumin the treatment of cancers in various systems of the human body, their inhibitory effects on tumor survival and tumor microenvironment, and their potential mechanisms. Additionally, this review proposes future application prospects ofDendrobiumin cancer therapy to promote further research and future extensive clinical applications ofDendrobiumin cancer therapy.